Goldman Sachs’s Fractyl Health GUTS Stock Holding History

Goldman Sachs’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.3K	Sell	68,433 -3,356,764	-98%	-$3.09M	﹤0.01%	6333
2025 Q4	$7.54M	Buy	3,425,197 +2,934,749	+598%	+$4.72M	﹤0.01%	3360
2025 Q3	$780K	Buy	490,448 +349,390	+248%	+$453K	﹤0.01%	5206
2025 Q2	$229K	Buy	141,058 +53,225	+61%	+$86K	﹤0.01%	5593
2025 Q1	$105K	Sell	87,833 -42,255	-32%	-$67.5K	﹤0.01%	5779
2024 Q4	$268K	Buy	130,088 +70,518	+118%	+$164K	﹤0.01%	5533
2024 Q3	$151K	Buy	59,570 +41,149	+223%	+$134K	﹤0.01%	5517
2024 Q2	$78.7K	Buy	+18,421	New	+$119K	﹤0.01%	5425

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs's GUTS Position: Q1 2026 in Review

Goldman Sachs reduced its Fractyl Health (GUTS) stake by 98% in Q1 2026, selling an estimated $3.09M and leaving 68,433 shares worth $31.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6333.

Goldman Sachs first reported a position in GUTS in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.54M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

Goldman Sachs held 68,433 shares of Fractyl Health worth $31.3K as of Q1 2026.
Goldman Sachs sold 3,356,764 Fractyl Health shares in Q1 2026, an estimated $3.09M.
Fractyl Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6333 holding.
Goldman Sachs first reported a position in Fractyl Health in Q2 2024 and has held it in 8 quarters since.
Goldman Sachs's Fractyl Health position peaked at $7.54M in Q4 2025.
83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.